What is your approach to maintenance treatment in a patient with Sjogren's who received rituximab for mononeuritis multiplex?

The data supporting the use of maintenance DMARDs, in this scenario, is limited. On the other hand, there is some evidence that relapse is common. Therefore, agents such as Azathioprine, MFM or maintenance Rituximab, should be considered, akin to the management approach for ANCA vasculitis. Managing neuropathic pain, in those with residual symptoms despite systemic steroids and initial immunosuppressive therapy (i.e. Rituximab in this case) is also important, using agents such as Pregabalin, Gab...